Zobrazeno 1 - 10
of 311
pro vyhledávání: '"Robert T, Chen"'
Autor:
Rebecca E Chandler, James Milligan, Emmanuelle Espie, Katharina Hartmann, Madhava Ram Balakrishnan, Daniel Brasseur, Philip Bryan, Corinne Jouquelet-Royer, Linda Nesbitt, Shanthi Pal, Alexander Precioso, Paulo Takey, Robert T Chen
Publikováno v:
BMJ Global Health, Vol 9, Iss 3 (2024)
This analysis describes the successes, challenges and opportunities to improve global vaccine safety surveillance as observed by the Vaccine Safety Working Group from its role as a platform of exchange for stakeholders responsible for monitoring the
Externí odkaz:
https://doaj.org/article/e72c4727d6544d8c81ab20090652d1a9
Autor:
Patrick L F Zuber, Robert T Chen, Marion Gruber, David C Kaslow, Brigitte K Giersing, Martin H Friede
Publikováno v:
BMJ Global Health, Vol 6, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/dd03b67736bb4ee8b790af898f7c70dc
Autor:
Brett, Leav, Walter, Straus, Phil, White, Alison, Leav, Tashawnee, Gaines, Grace, Maggiacomo, Denny, Kim, Emily R, Smith, Marc, Gurwith, Robert T, Chen
Publikováno v:
Vaccine. 40:5275-5293
The Brighton Collaboration Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO) Working Group has prepared standardized templates to describe the key considerations for the benefit-risk assessment of several vaccine platform technologies, incl
Autor:
Pedro M Folegatti, Daniel Jenkin, Susan Morris, Sarah Gilbert, Denny Kim, James S. Robertson, Emily R. Smith, Emalee Martin, Marc Gurwith, Robert T. Chen
Publikováno v:
Vaccine. 40:5248-5262
Replication-deficient adenoviral vectors have been under investigation as a platform technology for vaccine development for several years and have recently been successfully deployed as an effective COVID-19 counter measure. A replication-deficient a
Autor:
Deborah A. Gust, Sanjyot Shinde, Sherri L. Pals, Felicia Hardnett, Robert T. Chen, Travis Sanchez
Publikováno v:
Journal of Epidemiology and Global Health, Vol 3, Iss 1 (2019)
There is increased emphasis on physician attention to the overall health and wellness of homosexual and bisexual men, though little is known about the health-related attitudes of these groups. This study determined factors associated with the health
Externí odkaz:
https://doaj.org/article/a16b770073d54ca1b3f4c5c6d8b532e5
Autor:
Deborah A. Gust, Sanjyot Shinde, Sherri L. Pals, Felicia Hardnett, Robert T. Chen, Travis Sanchez
Publikováno v:
Journal of Epidemiology and Global Health, Vol 3, Iss 4 (2019)
Externí odkaz:
https://doaj.org/article/cba4f40a85af4eb8951842e27e085220
The Brighton Collaboration Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO) Working Group has prepared standardized templates to describe the key considerations for the benefit-risk assessment of several vaccine platform technologies, incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c9c9b5cac525998f35cbf554a67dc8
Autor:
Mimi Darko, Ruth A. Karron, Jakob P. Cramer, Melanie Saville, Marion F. Gruber, Gerald Voss, Robert T. Chen, Nicole Lurie, Jeanne-Marie Jacquet, Ajoke Sobanjo-ter Meulen, Charlie Weller, Nadia Tornieporth, Beate Kampmann
Publikováno v:
Vaccine
Infectious diseases may cause serious morbidity and mortality in pregnant women, their foetuses, and infants; the risk associated with any newly emerging infectious disease (EID) is likely unknown at the time of its emergence. While the ongoing SARS-
Autor:
David Lee, Björn Wettermark, Christine Y. Lu, Stephen B. Soumerai, Robert T. Chen, Sharon‐Lise T. Normand, Art Sedrakyan, Danica Marinac‐Dabic, Daniel B. Horton, Sonia Hernandez‐Diaz, Tamar Lasky, Krista F. Huybrechts, Claudia Manzo, Emil Cochino, Hanna M. Seidling, David W. Bates, Bennett Levitan, Rachael L. DiSantostefano, Scott Evans
Publikováno v:
Textbook of Pharmacoepidemiology. :387-463
Autor:
Frederic Peyrade, Graham P. Collins, Yihua Lee, Jutta K. Neuenburg, Michael Wang, Robert T. Chen, Geoffrey Chong, Karl Eckert, Constantine S. Tam, Radhakrishnan Ramchandren, Lionel Karlin, Ka Lung Wu, Mark Bishton, Paul Eliadis, Wojciech Jurczak
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-8 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Ibrutinib plus venetoclax, given with an ibrutinib lead-in, has shown encouraging clinical activity in early phase studies in mantle cell lymphoma (MCL). The ongoing phase 3 SYMPATICO study evaluates the safety and efficacy of concurrently administer